OTRAITHALAI VALI(MIGRAINE)-SIDDHA MEDICINE FOR SATHIKKAI CHOORANAM

PHASE II NON-RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA DRUG SATHIKKAI CHOORANAM IN ORUTHALAI VAADHABEDHAM (MIGRAINE)-IN BOTH GENDER OF AGE BETWEEN 20-45 YEARS PATIENTS ATTENDING OPD AT AAGHIM ATTACHED WITH GSMC

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021602

Enrollment

Registered

2019-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G892- Chronic pain, not elsewhere classified

Interventions

Intervention1: sathikkai chooranam: dosage:500mg bd hot water 48days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: hemicranial pain photophobia

Exclusion criteria

Exclusion criteria: sinusitis opthomologic problems

Design outcomes

Primary

Measure	Time frame
Pain reduceTimepoint: 0	—

Secondary

Measure	Time frame
Clinical symptoms reduceTimepoint: 0	—

Countries

India

Contacts

Public ContactSakthivel

government siddha medical college

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026